The Hindu·3 min read·medium

USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh

R
Rajulapudi Srinivas
USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh
AI Summary

The USFDA and Andhra Pradesh's Drug Control Administration held a workshop to discuss improving pharmaceutical manufacturing standards and regulatory collaboration. The event focused on ensuring drug quality through scientific approaches and rigorous inspection methodologies.

The officials of the Drug Control Administration (DCA) in Andhra Pradesh and U.S. Food and Drug Administration (USFDA) discussed ways to strengthen global regulatory collaboration and promote scientific pharmaceutical manufacturing at the Regulatory Workshop–2026 in the city on Friday.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthbusinessscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh — Headlinne — headlinne